KRT6A knockdown rescued the disease-associated downregulation of these molecules in rosacea and psoriasis mouse models (Supplementary Fig. 8E), suggesting that KRT6A may contribute to skin inflammation by modulating barrier function. Here, KRT6A is linked to rosacea.